Literature DB >> 35679431

Levels of abdominal adipose tissue and metabolic-associated fatty liver disease (MAFLD) in middle age according to average fast-food intake over the preceding 25 years: the CARDIA Study.

Andrew O Odegaard1, David R Jacobs2, Lisa B Van Wagner3, Mark A Pereira2.   

Abstract

BACKGROUND: Higher levels of intra-abdominal adipose tissue (IAAT) comprising visceral adipose tissue (VAT), intermuscular adipose tissue (IMAT), and liver fat are posited drivers of obesity-related chronic disease risk. Fast food is hypothesized to contribute to IAAT patterns.
OBJECTIVES: We quantified levels of abdominal subcutaneous adipose tissue (SAT), IAAT, and odds of metabolic-associated fatty liver disease (MAFLD) in middle age according to average fast-food intake over the preceding 25 y.
METHODS: We analyzed data from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Participants underwent 6 clinical exams and measurements over 25 y with computed tomography-measured VAT, SAT, and IMAT (n = 3156), plus MAFLD defined by liver attenuation (≤40 Hounsfield units) and 1 metabolic abnormality at year 25 (2010, n = 3001, n cases = 302). We estimated means of VAT, SAT, IMAT, and liver attenuation at the year 25 exam according to categories of average fast-food intake over the previous 25 y adjusted for sociodemographic and lifestyle factors and logistic regression to estimate the odds ratio of MAFLD at year 25.
RESULTS: With higher average fast-food intake over 25 y (categorized as follows: never-1×/mo, >1×-3×/mo, 1-<2×/wk, 2-<3×/wk, ≥3×/wk), there were monotonic higher levels of VAT (98.5, 127.6, 134.5, 142.0, 145.5 cm3), P-trend < 0.0001, which were consistent across anthropometrically classified obesity categories. There was a similar pattern with liver fat. There were higher levels of IMAT and SAT with higher fast-food intake (P-trend = 0.003, 0.0002, respectively), with amounts leveling off at ≥2×/wk. In addition, compared with participants who ate fast food never-1×/mo, there were monotonic higher odds of having MAFLD at year 25 with higher average fast-food intake, with participants who ate fast food ≥3×/wk having an OR of MAFLD = 5.18 (95% CI: 2.87, 9.37).
CONCLUSIONS: There were monotonic higher levels of VAT, liver fat, and odds of having MAFLD in middle age according to higher average fast-food intake over the preceding 25 y.
© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.

Entities:  

Keywords:  MAFLD; dietary intake; fast-food; obesity; visceral adipose tissue

Mesh:

Year:  2022        PMID: 35679431      PMCID: PMC9257467          DOI: 10.1093/ajcn/nqac079

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   8.472


  38 in total

Review 1.  Diets and morbid tissues--history counts, present counts.

Authors:  Yaakov Henkin; Julia Kovsan; Yftach Gepner; Iris Shai
Journal:  Br J Nutr       Date:  2015-04       Impact factor: 3.718

Review 2.  MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.

Authors:  Mohammed Eslam; Arun J Sanyal; Jacob George
Journal:  Gastroenterology       Date:  2020-02-08       Impact factor: 22.682

3.  Predictors of Ectopic Fat in Humans.

Authors:  Mauro Zamboni; Andrea P Rossi; Francesco Fantin; Simona L Budui; Elena Zoico; Giulia A Zamboni; Gloria Mazzali
Journal:  Curr Obes Rep       Date:  2014-12

4.  Diet and adipose tissue distributions: The Multi-Ethnic Study of Atherosclerosis.

Authors:  R V Shah; V L Murthy; M A Allison; J Ding; M Budoff; A C Frazier-Wood; J A C Lima; L Steffen; D Siscovick; K L Tucker; P Ouyang; S A Abbasi; K Danielson; M Jerosch-Herold; D Mozaffarian
Journal:  Nutr Metab Cardiovasc Dis       Date:  2015-12-29       Impact factor: 4.222

5.  Quality of Meals Consumed by US Adults at Full-Service and Fast-Food Restaurants, 2003-2016: Persistent Low Quality and Widening Disparities.

Authors:  Junxiu Liu; Colin D Rehm; Renata Micha; Dariush Mozaffarian
Journal:  J Nutr       Date:  2020-04-01       Impact factor: 4.798

6.  Physical activity in young adults and incident hypertension over 15 years of follow-up: the CARDIA study.

Authors:  Emily D Parker; Kathryn H Schmitz; David R Jacobs; Donald R Dengel; Pamela J Schreiner
Journal:  Am J Public Health       Date:  2007-02-28       Impact factor: 9.308

7.  Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease.

Authors:  Jiantao Ma; Rachel Hennein; Chunyu Liu; Michelle T Long; Udo Hoffmann; Paul F Jacques; Alice H Lichtenstein; Frank B Hu; Daniel Levy
Journal:  Gastroenterology       Date:  2018-03-29       Impact factor: 22.682

8.  Isocaloric Substitution of Dietary Carbohydrate Intake with Fat Intake and MRI-Determined Total Volumes of Visceral, Subcutaneous and Hepatic Fat Content in Middle-Aged Adults.

Authors:  Christa Meisinger; Susanne Rospleszcz; Elke Wintermeyer; Roberto Lorbeer; Barbara Thorand; Fabian Bamberg; Annette Peters; Christopher L Schlett; Jakob Linseisen
Journal:  Nutrients       Date:  2019-05-23       Impact factor: 5.717

9.  Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars.

Authors:  Panu K Luukkonen; Sanja Sädevirta; You Zhou; Brandon Kayser; Ashfaq Ali; Linda Ahonen; Susanna Lallukka; Véronique Pelloux; Melania Gaggini; Ching Jian; Antti Hakkarainen; Nina Lundbom; Helena Gylling; Anne Salonen; Matej Orešič; Tuulia Hyötyläinen; Marju Orho-Melander; Aila Rissanen; Amalia Gastaldelli; Karine Clément; Leanne Hodson; Hannele Yki-Järvinen
Journal:  Diabetes Care       Date:  2018-05-29       Impact factor: 19.112

Review 10.  Pathways and mechanisms linking dietary components to cardiometabolic disease: thinking beyond calories.

Authors:  K L Stanhope; M I Goran; A Bosy-Westphal; J C King; L A Schmidt; J-M Schwarz; E Stice; A C Sylvetsky; P J Turnbaugh; G A Bray; C D Gardner; P J Havel; V Malik; A E Mason; E Ravussin; M Rosenbaum; J A Welsh; C Allister-Price; D M Sigala; M R C Greenwood; A Astrup; R M Krauss
Journal:  Obes Rev       Date:  2018-05-14       Impact factor: 9.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.